Form 8-K - Current report:
SEC Accession No. 0001193125-25-211349
Filing Date
2025-09-22
Accepted
2025-09-22 16:19:42
Documents
14
Period of Report
2025-09-22
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d57621d8k.htm   iXBRL 8-K 26637
2 EX-99.1 d57621dex991.htm EX-99.1 9953
6 GRAPHIC g57621g0922234250418.jpg GRAPHIC 1542
  Complete submission text file 0001193125-25-211349.txt   156111

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cvs-20250922.xsd EX-101.SCH 2852
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cvs-20250922_lab.xml EX-101.LAB 17234
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cvs-20250922_pre.xml EX-101.PRE 10814
17 EXTRACTED XBRL INSTANCE DOCUMENT d57621d8k_htm.xml XML 3520
Mailing Address ONE CVS DR. WOONSOCKET RI 02895
Business Address ONE CVS DR. WOONSOCKET RI 02895 4017651500
CVS HEALTH Corp (Filer) CIK: 0000064803 (see all company filings)

EIN.: 050494040 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-01011 | Film No.: 251330251
SIC: 5912 Retail-Drug Stores and Proprietary Stores
(CF Office: 07 Trade & Services)